Description

🖼️ Tool Name:
Immunai

🔖 Tool Category:
Forecasting & Applied ML / Data Preparation & Cleaning — it falls under the category of AI platforms specialized in multi-omics & immunology data processing, predictive modeling, and mechanistic insight generation for drug discovery.

✏️ What does this tool offer?
Immunai is a biotechnology AI company that decodes the immune system using single-cell multi-omic data to guide therapeutic discovery. They generate, harmonize, and analyze immune data to build models that link immune features with treatment responses and inform clinical and preclinical decisions. 

What does the tool actually deliver based on user experience?
• Creation of high-resolution immune profiles (single-cell RNA, proteomics, TCR/BCR sequencing) from patient samples. 
• A unified immune atlas database, “AMICA”, combining internal and public immune datasets. 
• An AI engine (Immunodynamics Engine, IDE) that computes immune features, predicts response, and links mechanisms to outcomes. 
• Recommendations and explainable scoring (why certain immune signals are tied to clinical outcomes). 
• Use in target discovery, trial optimization (patient stratification, dose selection), and validating therapeutic hypotheses. 

🤖 Does it include automation?
Yes — Immunai automates multiple parts of the workflow:
• Processing and harmonizing multi-omic immune data (data ingestion, normalization). 
• Feature extraction and immune signature modeling via machine learning. 
• Hypothesis recommendation and scoring based on the computed models. 
• Integration of data with prior knowledge (AMICA) to support interpretability and benchmarking. 

💰 Pricing Model:
Enterprise / collaboration-based (custom pricing via partnerships with biopharma).

🆓 Free Plan Details:
No public free tier — access is likely via partnership or contracted collaborations.

💳 Paid Plan Details:
Contracts with pharma companies for use of ImmunaI’s AI and data platform, integration, and joint projects (e.g. collaboration with AstraZeneca). 

🧭 Access Method:
• Via Immunai’s cloud/AI platform and web interface.
• Through biopharma collaborations or project-based access.
• Integration into drug discovery workflows (preclinical, clinical) and data sharing agreements with partners.

🔗 Experience Link:

https://www.immunai.com

Pricing Details

💰 Pricing Model: Enterprise / collaboration-based (custom pricing via partnerships with biopharma). 🆓 Free Plan Details: No public free tier — access is likely via partnership or contracted collaborations. 💳 Paid Plan Details: Contracts with pharma companies for use of ImmunaI’s AI and data platform, integration, and joint projects (e.g. collaboration with AstraZeneca).